Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
Biaryl inhibitors of bruton's tyrosine kinase
US10081619B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10081619-B2 |
| Application number | US-201715699857-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 8, 2017 |
| Priority date | Dec 11, 2013 |
| Publication date | Sep 25, 2018 |
| Grant date | Sep 25, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound represented by the following formula: or a pharmaceutically acceptable salt thereof. 2. The compound of claim 1 , wherein the compound is represented by the following formula: or a pharmaceutically acceptable salt thereof. 3. A compound represented by the following formula: or a pharmaceutically acceptable salt thereof. 4. The compound of claim 3 , wherein the compound is represented by the following formula:
Assignees
Inventors
Classifications
Immunomodulators · CPC title
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
Antineoplastic agents · CPC title
Immunosuppressants, e.g. drugs for graft rejection · CPC title
Drugs for immunological or allergic disorders · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10081619B2 cover?
- The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
- Who is the assignee on this patent?
- Biogen Ma Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D403/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).